PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
13-Oct-2025 Latin America Accelerates Health Data Interoperability With openEHR: A Regional Model for Global Digital Health Transformation ACCESS Newswire
13-Oct-2025 REACtiVe-2 Phase 1 Data Featuring Mitazalimab Demonstrate Immune Activation in Metastatic Pancreatic Cancer - To be Presented at ESMO 2025 ACCESS Newswire
13-Oct-2025 New Report by CAPS: Asian Philanthropy Positioned to Lead on Maternal and Child Health as Foreign Aid Retreats Businesswire
13-Oct-2025 Transgene and BioInvent to Present Translational Data and Updated Clinical Results on Armed Oncolytic Virus BT-001, at ESMO 2025 ACCESS Newswire
13-Oct-2025 Anti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed 26.7 Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase 2 EDGE-Gastric Study Businesswire
12-Oct-2025 Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress ACCESS Newswire
12-Oct-2025 IOCDF Launches #TogetherAgainstOCD Global Campaign With Ambassador Aly Raisman for OCD Awareness Week ACCESS Newswire
10-Oct-2025 Medincell: FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder Businesswire
10-Oct-2025 Medincell : La FDA approuve l’extension d’indication de UZEDY® pour le traitement de patients atteints de trouble bipolaire de type I Businesswire
10-Oct-2025 Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
10-Oct-2025 Rosen Law Firm Urges aTyr Pharma, Inc. (NASDAQ: ATYR) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights Businesswire
10-Oct-2025 Axway Named a Leader in the 2025 Gartner® Magic Quadrant™ for API Management for the 10th Time Businesswire
10-Oct-2025 IGC Pharma Announces Results of 2025 Annual Meeting of Stockholders ACCESS Newswire
10-Oct-2025 Mundipharma meldet Abschluss der Patientenanmeldung für die klinische Phase-III-Studie ReSPECT zu REZZAYO® (Rezafungin) Businesswire
10-Oct-2025 Mundipharma anuncia finalização das inscrições de pacientes no ensaio clínico ReSPECT de Fase III sobre o REZZAYO® (rezafungina) Businesswire
10-Oct-2025 Number of Shares and Voting Rights of ADOCIA as of September 30th, 2025 Businesswire
10-Oct-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
10-Oct-2025 ProSpecBio Launches Activin-A Recombinant Protein, Empowering Global Research in Inflammation and Brain Injury Businesswire
10-Oct-2025 Mundipharma宣布,REZZAYO®(雷扎芬淨)III期ReSPECT臨床試驗已完成病患招募 Businesswire
10-Oct-2025 Mundipharma宣布,REZZAYO®(雷扎芬净)III期ReSPECT临床试验已完成患者招募 Businesswire